Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bulk RNA-seq on NOD mice prostate tissues treated with etanercept

ABSTRACT: Bulk RNA-seq on NOD mice prostate tissues treated with etanercept

PROVIDER: PRJNA760533 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15714439_1.fastq.gz	Fastqsanger.gz
	SRR15714439_2.fastq.gz	Fastqsanger.gz
	SRR15714440_1.fastq.gz	Fastqsanger.gz
	SRR15714440_2.fastq.gz	Fastqsanger.gz
	SRR15714441_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Bulk RNA-seq on NOD mice prostate tissues treated with etanercept

Project description:Immunohistochemistry studies indicated that etanercept treatment reduced inflammation, epithlial proliferation, and epithelial NFkB activity in NOD prostate tissues compared to control treated mice. A bulk RNA-seq study was conducted on whole mouse prostate tissues from NOD mice treated with PBS control or etanercept for 5 weeks to identify putative pathways involved in these processes. These analyses determined differentially expressed genes and numerous enriched pathways yielding a greater understanding of pathways involved in prostate regression and inhibition of inflammation.

2022-02-16 | GSE183414 | GEO

Bulk RNA sequencing of prostate tissues from BPH model mice and treatment groups

Project description:We performed bulk RNA sequencing on fresh prostate tissue serial sections from five randomly selected mice per group.

2025-12-02 | GSE297417 | GEO

Bulk RNA sequencing of prostate tissues from BPH model mice and treatment groups

Project description:Bulk RNA sequencing of prostate tissues from BPH model mice and treatment groups

| PRJNA1263810 | ENA

Bulk RNA-seq analysis of prostate tissues treated with neoadjuvant ADT plus enzalutamide

Project description:Bulk RNA-seq analysis of prostate tissues treated with neoadjuvant ADT plus enzalutamide

| PRJNA759198 | ENA

MoDCs grown with/without Etanercept TNF inhibitor

Project description:The process for making monocyte derived DCs (moDCs) has been previously described (46). All analysis was performed on “day 5” immature DCs. Etanercept 10mg/mL was added to experimental wells on days 0, 2, and 4. We chose this concentration of etanercept as it approximates the plasma concentration of drug when given 50mg BIW. Keywords: Inhibition assay

2007-10-06 | GSE9239 | GEO

Effect of Etanercept on Active Pulmonary Tuberculosis in Rabbits

Project description:Treatment of chronic inflammatory diseases with tumor necrosis factor alpha antagonists has been associated with increased risk of tuberculosis (TB). We examined the usefulness of the rabbit model of active pulmonary TB for studying the impact of the human immune modulatory reagent etanercept on the host immune response. Control of Mycobacterium tuberculosis (Mtb) infection, disease pathology and the global transcriptional response in Mtb-infected lungs of rabbits were studied. Etanercept treatment exacerbated disease pathology and reduced bacillary control in the lungs, compared to infected untreated animals. The microarray experiments involves comparison of changes in gene expression between Mtb-HN878 infected and Etanercept treated and untreated rabbit lungs at 4 and 8 weeks post-treatment, starting at 4 weeks post-infection. New Zealand White rabbits were infected with Mtb HN878 at about 3.2log10 (on day 0). One group of rabbits were treated with Etanercept, starting at 4 weeks post-infection, for 4 or 8 weeks. Total RNA from lung tissues of treated and untreated animals were isolated at 4 and 8 weeks post treatment and used for microarray gene expression analysis.

2014-01-28 | E-GEOD-54442 | biostudies-arrayexpress

LNCAP xenograft prostate cancer progression model in NOD-SCID mice

Project description:LNCAP xenograft prostate cancer progression model in NOD-SCID mice

| PRJNA872388 | ENA

Effect of Etanercept on Active Pulmonary Tuberculosis in Rabbits

2014-01-28 | GSE54442 | GEO

Next Generation Sequencing of piRNAs in 3 prostate cancer tissues and 3 paired prostate tissues

Project description:Next Generation Sequencing of piRNAs in 3 prostate cancer tissues and 3 paired prostate tissues

| PRJNA600259 | ENA

Early tissue responses to etanercept in psoriasis lesions

Project description:Anti-TNF-alpha therapy has made a significant impact on the treatment of psoriasis. Despite being designed to neutralize TNF-alpha activity, the mechanism of action of these agents in the resolution of psoriasis remains unclear. The aim of this study was to better understand the mechanism of action of etanercept by examining very early changes in the lesional skin of psoriasis patients. 20 chronic plaque psoriasis patients were enrolled and received 50mg etanercept twice weekly. Skin biopsies were obtained before treatment and on days 1, 3, 7 and 14 post-treatment. Skin mRNA expression was analysed by microarray.

2014-06-07 | GSE47751 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data